The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & FDA Peptide Update: Category 2 Removals Explained BPC TB 5 Beverly Hills Rejuvenation Center The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post